It followed up from you asking what my point was after I posted your statement "That is the job of the company and they need to spell out exactly what trial results mean in terms that shareholders can understand.". For someone who has held since 2018 and not immediately pick-up on the BS @Mason14 posted and said "it make sense" is very concerning, maybe just focus on the announcement from the company.
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-164
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |